Explore Effects of Dietary Fish Oil in Human Skin
NCT03122912 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2021-05-06
Summary
The purpose of this study is to explore the potential differences in the skin of people who take fish oil versus soybean oil pills.
Conditions
- Aging Problems
Interventions
- DIETARY_SUPPLEMENT
-
Fish Oil
Capsules contain omega-3 fatty acids (fish oil). Dosage of 3180 mg of omega-3 fatty acids will be taken orally daily up to 16 weeks.
- DIETARY_SUPPLEMENT
-
Soybean Oil
Dosage will be 3000 mg of soybean oil taken orally daily for up to 16 weeks.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Gary Fisher, PhD · University of Michigan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-24
- Primary Completion
- 2021-02-01
- Completion
- 2021-02-01
Countries
- United States
Study Locations
More Related Trials
-
Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance
NCT03259412 ·Status: COMPLETED ·Phase: NA
-
Supplementation With Omega-3: Mechanism of Action
NCT02036307 ·Status: TERMINATED ·Phase: PHASE2
-
The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
NCT01692431 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effect of Fish Oil Concentrate on Skin Function
NCT07133477 ·Status: RECRUITING ·Phase: NA
-
Minimum Time Effect of Fish Oil on Arterial Stiffness
NCT06981364 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acid Supplementation in Older Adults
NCT01666392 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Omega-3 Fatty Acid Supplementation and Physical Training on Metabolic Health
NCT06533891 ·Status: WITHDRAWN ·Phase: NA
-
Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers
NCT05121766 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy Study on the Lipid-lowering Effect of Plant Sterols and Fish Oil
NCT01313988 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids on Markers of Inflammation
NCT01129050 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation
NCT04269876 ·Status: TERMINATED ·Phase: NA
-
Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and Lipids
NCT02670382 ·Status: COMPLETED ·Phase: NA
-
Plasma Diurnal Variation in and Absorption of EPA and DHA
NCT02661698 ·Status: COMPLETED ·Phase: NA
-
Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus
NCT06061510 ·Status: COMPLETED ·Phase: NA
-
Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy
NCT01690312 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids to Combat Sarcopenia
NCT02103842 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Fish Oil Monoglycerides on the Modulation of Mitochondrial Functions and Lactate Threshold
NCT03915535 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Fish Oil on Plasma Triglycerides in Adults
NCT00804427 ·Status: COMPLETED ·Phase: NA
-
Influence of Fish Oil Based Intravenous Fat Emulsions on the Epidermal Barrier Function
NCT02550860 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of Omega-3 Fatty Acid Supplementation in Acne Patients
NCT01764308 ·Status: TERMINATED ·Phase: PHASE3
-
Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure
NCT05822141 ·Status: RECRUITING ·Phase: NA
-
Eicosapentaenoic Acid (EPA)and Docosahexaenoic Acid Study
NCT01400490 ·Status: UNKNOWN ·Phase: NA
-
Impact of EPA and DHA Supplementation on Plasma Biomarkers of Inflammation (n3)
NCT01810003 ·Status: COMPLETED ·Phase: NA
-
n-3 Polyunsaturated Fatty Acids to Prevent and Treat Diabetic Neuropathy
NCT05145452 ·Status: TERMINATED ·Phase: NA
-
Effect of a Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and Endothelial Progenitor Cells (EPC's)
NCT00166088 ·Status: COMPLETED ·Phase: PHASE2